<i>Med Research</i>: Building Interdisciplinary Bridges and Leading Global Medical Innovation

Abstract

The field of human health is confronting unprecedented historic decisions. Breakthrough advances in contemporary medicine are fundamentally reshaping our understanding of disease and treatment paradigms: gene editing technology based on the clustered regularly interspaced short palindromic repeats-associated protein 9(CRISPR-Cas9) system now enables precise modification of pathogenic gene loci [1]; deep learning-driven medical image analysis significantly enhances early lesion detection capabilities, dramatically improving diagnostic accuracy [2]; and single-cell transcriptome sequencing systematically unveils the complex heterogeneity of human cellular functions [3]. However, there exists a significant imbalance between technological innovation and global health equity—breast cancer 5-year survival rates exceed 90% in high-income countries [4], whereas the burden of childhood infectious diseases remains persistently high in sub-Saharan Africa [5]; Simultaneously, as the da Vinci surgical robot achieves operational precision at the 0.1 mm level, low-income countries still face substantial gaps in even basic obstetric care coverage [6]. This structural contradiction, where technological inclusivity substantially lags behind the pace of scientific breakthroughs, has become a critical challenge for global health governance in the 21st century. The current medical research ecosystem faces multidimensional and interconnected challenges. Knowledge barriers resulting from disciplinary divisions have not been completely eliminated—basic scientists search for clues in the labyrinth of molecular mechanisms, clinicians identify patterns in vast repositories of case data, and public health decision-makers seek balance amid waves of emergent crises. Despite sharing the ultimate goal of improving human health, differences in disciplinary languages and methodological approaches often render collaboration difficult. Of greater concern is that the translational efficiency of academic achievements still falls significantly short of expectations: valuable research may miss optimal application windows due to publication delays or fail to reach regions in urgent need due to intractable language and resource barriers. When preclinical data for a new diabetes therapy require many years to enter practice guidelines [7], when research on neglected diseases progresses slowly due to insufficient commercial incentives [8], we recognize more clearly than ever that medical progress necessitates more open collaborative ecosystems and more agile knowledge dissemination mechanisms. As members of the global academic community, we clearly acknowledge the limitations of a single platform. The complex challenges of emerging infectious disease threats, chronic disease burdens, and imbalanced healthcare resource distribution necessarily demand the establishment of cross-domain collaborative mechanisms. The establishment of Med Research is not intended to disrupt existing systems, but rather to serve as a collaborative partner among countless explorers, adopting an open cooperative approach to build bridges between the profound mechanisms of basic research and the practical needs of clinical practice. We firmly believe that the true power of medicine lies in the dual breakthrough of deepening our understanding of disease mechanisms and promoting the inclusive translation of technological achievements—enabling the brilliance of gene sequencing technology to illuminate villages ravaged by tropical diseases, and the precision of artificial intelligence (AI)-driven diagnostics to benefit clinics in remote mountainous areas. By facilitating meaningful exchanges between cutting-edge technologies from developed countries and indigenous wisdom from developing nations, and by promoting intellectual interaction between molecular biologists and frontline physicians, each seemingly small spark of innovation will generate transformative impact through resonance within the global